| Interleukin-1–receptor antagonist in type 2 diabetes mellitus CM Larsen, M Faulenbach, A Vaag, A Vølund, JA Ehses, B Seifert, ... New England Journal of Medicine 356 (15), 1517-1526, 2007 | 2195 | 2007 |
| A choice of death–the signal-transduction of immune-mediated beta-cell apoptosis DL Eizirik, T Mandrup-Poulsen Diabetologia 44, 2115-2133, 2001 | 1161 | 2001 |
| A guiding map for inflammation MG Netea, F Balkwill, M Chonchol, F Cominelli, MY Donath, ... Nature immunology 18 (8), 826-831, 2017 | 795 | 2017 |
| Interleukin-6 and diabetes: the good, the bad, or the indifferent? OP Kristiansen, T Mandrup-Poulsen Diabetes 54 (suppl_2), S114-S124, 2005 | 791 | 2005 |
| The role of interleukin-1 in the pathogenesis of IDDM T Mandrup-Poulsen Diabetologia 39 (9), 1005-1029, 1996 | 741 | 1996 |
| Cytotoxicity of Human pI 7 Interleukin-1 for Pancreatic Islets of Langerhans K Bendtzen, T Mandrup-Poulsen, J Nerup, JH Nielsen, CA Dinarello, ... Science 232 (4757), 1545-1547, 1986 | 710 | 1986 |
| Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes MY Donath, J Størling, K Maedler, T Mandrup-Poulsen Journal of molecular medicine 81, 455-470, 2003 | 658 | 2003 |
| Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in … AK Cardozo, F Ortis, J Storling, YM Feng, J Rasschaert, M Tonnesen, ... Diabetes 54 (2), 452-461, 2005 | 632 | 2005 |
| An immune origin of type 2 diabetes? H Kolb, T Mandrup-Poulsen Diabetologia 48, 1038-1050, 2005 | 584 | 2005 |
| Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus: a hypothesis K Borch-Johnsen, T Mandrup-Poulsen, B Zachau-Christiansen, G Joner, ... The Lancet 324 (8411), 1083-1086, 1984 | 522 | 1984 |
| Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes CM Larsen, M Faulenbach, A Vaag, JA Ehses, MY Donath, ... Diabetes care 32 (9), 1663-1668, 2009 | 500 | 2009 |
| Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans T Mandrup-Poulsen, K Bendtzen, J Nerup, CA Dinarello, M Svenson, ... Diabetologia 29, 63-67, 1986 | 464 | 1986 |
| Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. S Baekkeskov, M Landin, JK Kristensen, S Srikanta, GJ Bruining, ... The Journal of clinical investigation 79 (3), 926-934, 1987 | 436 | 1987 |
| The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation H Kolb, T Mandrup-Poulsen Diabetologia 53 (1), 10-20, 2010 | 433 | 2010 |
| Role of IL-1β in type 2 diabetes CA Dinarello, MY Donath, T Mandrup-Poulsen Current Opinion in Endocrinology, Diabetes and Obesity 17 (4), 314-321, 2010 | 428 | 2010 |
| Poor pregnancy outcome in women with type 2 diabetes TD Clausen, E Mathiesen, P Ekbom, E Hellmuth, T Mandrup-Poulsen, ... Diabetes care 28 (2), 323-328, 2005 | 401 | 2005 |
| Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. T Mandrup-Poulsen, K Bendtzen, CA Dinarello, J Nerup Journal of immunology (Baltimore, Md.: 1950) 139 (12), 4077-4082, 1987 | 393 | 1987 |
| Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes C Cavelti-Weder, A Babians-Brunner, C Keller, MA Stahel, M Kurz-Levin, ... Diabetes care 35 (8), 1654-1662, 2012 | 386 | 2012 |
| Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials A Moran, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ... The Lancet 381 (9881), 1905-1915, 2013 | 382 | 2013 |
| Targeting innate immune mediators in type 1 and type 2 diabetes MY Donath, CA Dinarello, T Mandrup-Poulsen Nature Reviews Immunology 19 (12), 734-746, 2019 | 364 | 2019 |
